Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome

ClinicalTrials.gov ID: NCT01237587

Public ClinicalTrials.gov record NCT01237587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether duloxetine is safe and effective in the treatment of adolescents with Juvenile Primary Fibromyalgia Syndrome (JPFS). This trial consists of two distinct study periods. A blinded treatment period of 13 weeks and an open label extension period of 26 weeks.

Study identification

NCT ID
NCT01237587
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
184 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
May 31, 2017 (Actual)
Completion
Nov 28, 2017 (Actual)
Last update posted
Sep 20, 2019

2011 – 2017

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
NoesisPharma Phoenix Arizona 85032 —
Loma Linda University School of Medicine Loma Linda California 92354 —
Synergy Clinical Research National City California 91950 —
Connecticut Clinical Trials LLC Cromwell Connecticut 06416 —
Associated Neurologists of Southern Connecticut Fairfield Connecticut 06824 —
Palm Beach Research Center West Palm Beach Florida 33409 —
Institute for Behavioral Medicine Smyrna Georgia 30080 —
Riley Hosptial for Children Indianapolis Indiana 46202 —
Kentucky Medical Research Center Lexington Kentucky 40504 —
Mercy Health Research St Louis Missouri 63141 —
Healthy Perspectives Innovative Mental Health Services, PL Nashua New Hampshire 03060 —
Albuquerque Neurosciences Albuquerque New Mexico 87109 —
Bioscience Research, LLC Mount Kisco New York 10549 —
Richmond Behavorial Associates Staten Island New York 10312 —
Neurobehavioral Clinical Research Canton Ohio 44718 —
Univ of Cincinnati College of Medicine Cincinnati Ohio 45219 —
North Star Research Middleburg Heights Ohio 44130 —
Neuropsychiatric Center Oklahoma City Oklahoma 73109 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
CRI Lifetree Philadelphia Pennsylvania 19139 —
Holston Medical Group Clinical Research Kingsport Tennessee 37660 —
Arthritis and Osteoporosis Center of South Texas San Antonio Texas 78232 —
Bateman Horne Center of Excellence Salt Lake City Utah 84102 —
NeuroScience, Inc. Herndon Virginia 20170-2613 —
Advanced Pain Management Virginia Beach Virginia 23505 —
Northwest Clinical Research Center Bellevue Washington 98007-4209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01237587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 20, 2019 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01237587 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →